跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
ATLANTISCAN
Authorized
STANDARD
ATLANTISCAN
Nova Scotia Health Authority
🇨🇦 Health Canada
Approval Date
Feb 5, 2026
Approval ID
159252b29ab7b8f9
Company
Nova Scotia Health Authority
Type
Standard
Approval Details
Approval Id
159252b29ab7b8f9
Drug Approval Canada Name
ATLANTISCAN
Product Name
ATLANTISCAN
Status
Marketed
Drug Class
Radiopharmaceutical
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Schedule C
Ahfs
78:00.00 , 36:00.00
Atc Original
V09IX04 FLUDEOXYGLUCOSE (18F)
Aig Number
0152591018
Company Name
Nova Scotia Health Authority
Company Address
1276 South Park Street, 1071b Centennial Building Cyclotron Facility Halifax Nova Scotia Canada B3H 2Y9
Company Detail Path
/organization/nova-scotia-health-authority
Company Information
Pharmaceutical Company Name
Nova Scotia Health Authority
Country Name
Canada
Province Name
Nova Scotia
City Name
halifax,nova scotia,country_ca
Address
90 Lovett Lake Crt
Website
http://www.nshealth.ca
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Feb 5, 2026
Approval ID
159252b29ab7b8f9
Type
Standard
Back to Health Canada Approvals
ATLANTISCAN - Health Canada Drug Approval Details